PAS kinase: Integrating nutrient sensing with nutrient partitioning

Seminars in Cell and Developmental Biology

Volumn 23, Issue 6, 2012, Pages 626-630

  Cardon, Caleb M ^a   Rutter, Jared ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

AMPK; Growth; Nutrient; PAS kinase; TOR

Indexed keywords

ADENYLATE KINASE; PAS KINASE; PROTEIN KINASE; TARGET OF RAPAMYCIN KINASE; UNCLASSIFIED DRUG;

DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; MAMMAL; METABOLIC REGULATION; NEOPLASM; NONHUMAN; NUTRIENT; OBESITY; REVIEW; SIGNAL TRANSDUCTION; YEAST;

MAMMALIA;

EID: 84865164084     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.12.007     Document Type: Review

References (55)

1. Hardie D.G. AMPK and autophagy get connected. EMBO J 2011, 30:634-635.
2. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011, 12:21-35.
3. Hardie D.G. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007, 8:774-785.
4. Shaw R.J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf) 2009, 196:65-80.
5. Hardie D.G. Roles of the AMP-activated/SNF1 protein kinase family in the response to cellular stress. Biochem Soc Symp 1999, 64:13-27.
6. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005, 1:15-25.
7. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
8. Rutter J., Michnoff C.H., Harper S.M., Gardner K.H., McKnight S.L. PAS kinase: an evolutionarily conserved PAS domain-regulated serine/threonine kinase. Proc Natl Acad Sci USA 2001, 98:8991-8996.
9. Hao H.X., Cardon C.M., Swiatek W., Cooksey R.C., Smith T.L., Wilde J., et al. PAS kinase is required for normal cellular energy balance. Proc Natl Acad Sci USA 2007, 104:15466-15471.
10. Smith T.L., Rutter J. Regulation of glucose partitioning by PAS kinase and Ugp1 phosphorylation. Mol Cell 2007, 26:491-499.
11. Moglich A., Ayers R.A., Moffat K. Structure and signaling mechanism of Per-ARNT-Sim domains. Structure 2009, 17:1282-1294.
12. Kitanishi K., Igarashi J., Hayasaka K., Hikage N., Saiful I., Yamauchi S., et al. Heme-binding characteristics of the isolated PAS-A domain of mouse Per2, a transcriptional regulatory factor associated with circadian rhythms. Biochemistry 2008, 47:6157-6168.
13. Stephenson K., Hoch J.A. PAS-A domain of phosphorelay sensor kinase A: a catalytic ATP-binding domain involved in the initiation of development in Bacillus subtilis. Proc Natl Acad Sci USA 2001, 98:15251-15256.
14. Soshilov A., Denison M.S. Role of the Per/Arnt/Sim domains in ligand-dependent transformation of the aryl hydrocarbon receptor. J Biol Chem 2008, 283:32995-33005.
15. Monson E.K., Ditta G.S., Helinski D.R. The oxygen sensor protein, FixL, of Rhizobium meliloti. Role of histidine residues in heme binding, phosphorylation, and signal transduction. J Biol Chem 1995, 270:5243-5250.
16. Amezcua C.A., Harper S.M., Rutter J., Gardner K.H. Structure and interactions of PAS kinase N-terminal PAS domain: model for intramolecular kinase regulation. Structure 2002, 10:1349-1361.
17. Grose J.H., Smith T.L., Sabic H., Rutter J. Yeast PAS kinase coordinates glucose partitioning in response to metabolic and cell integrity signaling. EMBO J 2007, 26:4824-4830.
18. Rutter J., Probst B.L., McKnight S.L. Coordinate regulation of sugar flux and translation by PAS kinase. Cell 2002, 111:17-28.
19. Kikani C.K., Antonysamy S.A., Bonanno J.B., Romero R., Zhang F.F., Russell M., et al. Structural bases of PAS domain-regulated kinase (PASK) activation in the absence of activation loop phosphorylation. J Biol Chem 2010, 285:41034-41043.
20. Johnson L.N., Noble M.E., Owen D.J. Active and inactive protein kinases: structural basis for regulation. Cell 1996, 85:149-158.
21. Mazanka E., Alexander J., Yeh B.J., Charoenpong P., Lowery D.M., Yaffe M., et al. The NDR/LATS family kinase Cbk1 directly controls transcriptional asymmetry. PLoS Biol 2008, 6:e203.
22. Daran J.M., Dallies N., Thines-Sempoux D., Paquet V., Francois J. Genetic and biochemical characterization of the UGP1 gene encoding the UDP-glucose pyrophosphorylase from Saccharomyces cerevisiae. Eur J Biochem 1995, 233:520-530.
23. Szekely E., Montgomery D.L. Glucose represses transcription of Saccharomyces cerevisiae nuclear genes that encode mitochondrial components. Mol Cell Biol 1984, 4:939-946.
24. Parrou J.L., Enjalbert B., Plourde L., Bauche A., Gonzalez B., Francois J. Dynamic responses of reserve carbohydrate metabolism under carbon and nitrogen limitations in Saccharomyces cerevisiae. Yeast 1999, 15:191-203.
25. Schuller H.J., Entian K.D. Isolation and expression analysis of two yeast regulatory genes involved in the derepression of glucose-repressible enzymes. Mol Gen Genet 1987, 209:366-373.
26. Wright R.M., Poyton R.O. Release of two Saccharomyces cerevisiae cytochrome genes, COX6 and CYC1, from glucose repression requires the SNF1 and SSN6 gene products. Mol Cell Biol 1990, 10:1297-1300.
27. Wilson W.A., Hawley S.A., Hardie D.G. Glucose repression/derepression in budding yeast: SNF1 protein kinase is activated by phosphorylation under derepressing conditions, and this correlates with a high AMP:ATP ratio. Curr Biol 1996, 6:1426-1434.
28. Chandrashekarappa D.G., McCartney R.R., Schmidt M.C. Subunit and domain requirements for adenylate-mediated protection of Snf1 activation loop from dephosphorylation. J Biol Chem 2011.
29. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L., Bonenfant D., et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 2002, 10:457-468.
30. Helliwell S.B., Wagner P., Kunz J., Deuter-Reinhard M., Henriquez R., Hall M.N. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol Biol Cell 1994, 5:105-118.
31. Beck T., Hall M.N. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature 1999, 402:689-692.
32. Kamada Y., Fujioka Y., Suzuki N.N., Inagaki F., Wullschleger S., Loewith R., et al. Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol Cell Biol 2005, 25:7239-7248.
33. Beretta L., Gingras A.C., Svitkin Y.V., Hall M.N., Sonenberg N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 1996, 15:658-664.
34. Martin D.E., Soulard A., Hall M.N. TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1. Cell 2004, 119:969-979.
35. Crespo J.L., Hall M.N. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2002, 66:579-591. table of contents.
36. Altmann M., Schmitz N., Berset C., Trachsel H. A novel inhibitor of cap-dependent translation initiation in yeast: p20 competes with eIF4G for binding to eIF4E. EMBO J 1997, 16:1114-1121.
37. Wei C.L., Kainuma M., Hershey J.W. Characterization of yeast translation initiation factor 1A and cloning of its essential gene. J Biol Chem 1995, 270:22788-22794.
38. Schmidt A., Kunz J., Hall M.N. TOR2 is required for organization of the actin cytoskeleton in yeast. Proc Natl Acad Sci USA 1996, 93:13780-13785.
39. Kunz J., Henriquez R., Schneider U., Deuter-Reinhard M., Movva N.R., Hall M.N. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 1993, 73:585-596.
40. Jacinto E., Loewith R., Schmidt A., Lin S., Ruegg M.A., Hall A., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004, 6:1122-1128.
41. Schmidt A., Bickle M., Beck T., Hall M.N. The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 1997, 88:531-542.
42. Cardon CM, Beck T, Hall MN, Rutter J. PAS kinase promotes cell survival and growth via activation of Rho1. Sci Signal, in press.
43. Helliwell S.B., Schmidt A., Ohya Y., Hall M.N. The Rho1 effector Pkc1, but not Bni1, mediates signalling from Tor2 to the actin cytoskeleton. Curr Biol 1998, 8:1211-1214.
44. Qadota H., Python C.P., Inoue S.B., Arisawa M., Anraku Y., Zheng Y., et al. Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-beta-glucan synthase. Science 1996, 272:279-281.
45. Jansen J.M., Wanless A.G., Seidel C.W., Weiss E.L. Cbk1 regulation of the RNA-binding protein Ssd1 integrates cell fate with translational control. Curr Biol 2009, 19:2114-2120.
46. Berset C., Trachsel H., Altmann M. The TOR (target of rapamycin) signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1998, 95:4264-4269.
47. Hardie D.G. AMPK and Raptor: matching cell growth to energy supply. Mol Cell 2008, 30:263-265.
48. Carew J.S., Kelly K.R., Nawrocki S.T. Mechanisms of mTOR inhibitor resistance in cancer therapy. Target Oncol 2011, 6:17-27.
49. Cloughesy T.F., Yoshimoto K., Nghiemphu P., Brown K., Dang J., Zhu S., et al. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med 2008, 5:e8.
50. Inoki K., Kim J., Guan K.L. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 2011.
51. Fogarty S., Hardie D.G. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 2010, 1804:581-591.
52. da Silva Xavier G., Farhan H., Kim H., Caxaria S., Johnson P., Hughes S., et al. Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion. Diabetologia 2011, 54:819-827.
53. da Silva Xavier G., Rutter J., Rutter G.A. Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of preproinsulin and pancreatic duodenum homeobox 1 gene expression by glucose. Proc Natl Acad Sci USA 2004, 101:8319-8324.
54. Fontes G., Semache M., Hagman D.K., Tremblay C., Shah R., Rhodes C.J., et al. Involvement of Per-Arnt-Sim kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells. Diabetes 2009, 58:2048-2058.
55. Semplici F., Vaxillaire M., Fogarty S., Semache M., Bonnefond A., Fontes G., et al. A human mutation within the per-ARNT-sim (PAS) domain-containing protein kinase (PASK) causes basal insulin hypersecretion. J Biol Chem 2011.